Press Releases

Press Releases

These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools.

Feb 28, 2013
Agenus to Host Conference Call Beginning at 11 a.m. ET Today Agenus Inc. (Nasdaq: AGEN ), a biotechnology company working to develop novel immunology based treatments for cancers and infectious diseases, today announced its financial results and business highlights for the fourth quarter and year
Feb 27, 2013
HerpV is clinically the most advanced therapeutic vaccine for the treatment of genital herpes HerpV contains Agenus’ QS-21 Stimulon®* adjuvant currently being studied in 17 other clinical programs Agenus Inc. (Nasdaq: AGEN), a developer of therapeutic vaccines for cancer and infectious diseases,
Feb 26, 2013
Agenus Inc. (Nasdaq: AGEN), a developer of therapeutic vaccines for cancer and infectious diseases, today announced that the company will be presenting at the Cowen and Company 33 rd  Annual Healthcare Conference, which will be held at the Boston Marriott Copley Place Hotel. Dr.